A recent article in the Washington Post was headlined “‘Navigators’ for cancer patients: A nice perk or something more?”
A “nice perk”? It certainly seems like anything that would help to lessen the confusion for patients and help them obtain and adhere to treatment would improve outcomes and help keep costs down too. I took a closer look at the article and especially at the main research study it was reporting on.
Looking back over 2014, what are the highlights of the year when it comes to major stories about breast cancer and developments in cancer research?
Here are my picks for the top ten stories that taught me something new, or that seemed to me to offer fresh insights or helpful reinforcement on issues that have been around for a while.
What’s interesting in cancer research right now? What do we most need to know about? This is the latest post in a series in which we review several of the most notable cancer research stories that have come out over the previous two to three months.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Topics covered this time include medical decision-making, inherited breast cancer risk and a new drug for HER2-positive breast cancer.
